168 related articles for article (PubMed ID: 23927670)
1. Novel disease-modifying therapeutics for the treatment of Alzheimer's disease.
Léger GC; Massoud F
Expert Rev Clin Pharmacol; 2013 Jul; 6(4):423-42. PubMed ID: 23927670
[TBL] [Abstract][Full Text] [Related]
2. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine.
Nagakura A; Shitaka Y; Yarimizu J; Matsuoka N
Eur J Pharmacol; 2013 Mar; 703(1-3):53-61. PubMed ID: 23276665
[TBL] [Abstract][Full Text] [Related]
3. Treatment for Alzheimer's disease.
Wilcock GK
Int J Geriatr Psychiatry; 2000 Jun; 15(6):562-5. PubMed ID: 10861924
[No Abstract] [Full Text] [Related]
4. Advances in the treatment of Alzheimer's disease.
Schneider LS
Aging (Milano); 1998 Apr; 10(2):156-7. PubMed ID: 9666210
[No Abstract] [Full Text] [Related]
5. On the horizon: pathways for drug development in Alzheimer's disease.
Hake AM; Farlow MR
Clin Geriatr Med; 2004 Feb; 20(1):141-52. PubMed ID: 15062492
[No Abstract] [Full Text] [Related]
6. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
Masterman D
Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
[No Abstract] [Full Text] [Related]
7. [New options for the pharmacotherapy of Alzheimer's disease after the registration of memantine?].
Frölich L; Schmitt B; Calabrese P; Diener H; Förstl H; Gertz HJ; Hallauer JF; Hampel H; Ihl R; Rieke K; Riepe M; Supprian T
Dtsch Med Wochenschr; 2005 Feb; 130(8):408-12. PubMed ID: 15717252
[No Abstract] [Full Text] [Related]
8. Effective pharmacological management of Alzheimer's disease.
Atri A
Am J Manag Care; 2011 Nov; 17 Suppl 13():S346-55. PubMed ID: 22214392
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease: Seeing the signs early.
Leifer BP
J Am Acad Nurse Pract; 2009 Nov; 21(11):588-95. PubMed ID: 19900220
[TBL] [Abstract][Full Text] [Related]
10. Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014.
Schneider LS; Mangialasche F; Andreasen N; Feldman H; Giacobini E; Jones R; Mantua V; Mecocci P; Pani L; Winblad B; Kivipelto M
J Intern Med; 2014 Mar; 275(3):251-83. PubMed ID: 24605808
[TBL] [Abstract][Full Text] [Related]
11. [Alzheimer drugs for mild cognitive impairment].
Fellgiebel A
Neuropsychiatr; 2007; 21(3):230-3. PubMed ID: 17915184
[TBL] [Abstract][Full Text] [Related]
12. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
13. [Therapy in Alzheimer disease].
Kovács T
Orv Hetil; 2004 Apr; 145(17):925-8. PubMed ID: 15170971
[No Abstract] [Full Text] [Related]
14. The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease.
Rockwood K; Fay S; Gorman M
Int J Geriatr Psychiatry; 2010 Feb; 25(2):191-201. PubMed ID: 19548273
[TBL] [Abstract][Full Text] [Related]
15. A review on cholinesterase inhibitors for Alzheimer's disease.
Anand P; Singh B
Arch Pharm Res; 2013 Apr; 36(4):375-99. PubMed ID: 23435942
[TBL] [Abstract][Full Text] [Related]
16. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
Grossberg GT; Edwards KR; Zhao Q
J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
[TBL] [Abstract][Full Text] [Related]
17. How do we treat people with dementia in Croatia.
Mimica N; Presecki P
Psychiatr Danub; 2010 Jun; 22(2):363-6. PubMed ID: 20562784
[TBL] [Abstract][Full Text] [Related]
18. Common Alzheimer's drug flunks test of effectiveness. Initial improvements in cognitive ability made by cholinesterase inhibitors soon disappear.
Health News; 2004 Oct; 10(10):11. PubMed ID: 15584119
[No Abstract] [Full Text] [Related]
19. Symptomatic treatments in Alzheimer's disease in 2016: a study from Memory centers in France.
Hommet C; Novella JL; Auriacombe S; Vercelletto M; Berrut G; Belliard S; Desmidt T; Ceccaldi M
Geriatr Psychol Neuropsychiatr Vieil; 2016 Sep; 14(3):274-86. PubMed ID: 27651009
[TBL] [Abstract][Full Text] [Related]
20. [The pharmacotherapy of the cognitive disorders in Alzheimer's disease. Guidelines for rational drug use--a review].
Strnad J; Bahro M
Dtsch Med Wochenschr; 2000 Jul; 125(27):835-9. PubMed ID: 10929539
[No Abstract] [Full Text] [Related]
[Next] [New Search]
